| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |